ArticleExperimental & molecular medicine2025

RPS24 microexon isoform as a novel biomarker for estrogen receptor-positive breast cancer progression and therapeutic resistance.

Jiyeon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.